Yurek (jerzy) Paprocki MD, MBA

Dr. Yurek Paprocki is responsible for the development and implementation of Medical Affairs strategy for insulins at Novo Nordisk, Inc. located in Princeton, NJ.Outside of his employment with Novo Nordisk, Dr. Paprocki actively supports the need to provide education to people with diabetes. He is an Emeritus Chief Medical Officer for Peers for Progress, a global peer-to-peer patient support and education program of the AAFP Foundation. In addition, Dr. Paprocki serves as a member of Global Advisory Board for Peers for Progress.

Dr. Paprocki received his M.D. degree summa cum laude from Bialystok Medical University. He completed his residency and fellowship in Poland. He held clinical residencies in the United Kingdom, Egypt and Spain. In addition to his medical degree Dr. Paprocki earned his master’s degree in business administration (MBA) with honors from the Kelley School of Business at Indiana University in 2004. Dr. Paprocki started his pharmaceutical career in 1994. He has worked in Poland, Switzerland and, since 2000, in the USA. He held several positions of increasing responsibility in various departments, most recently in product and device development, medical education and medical affairs.